Limfedema klinikiniai tyrimai Texas
7 tyrimai dėl Limfedema ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements
- UT MD Anderson Cancer Center, Houston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-10-02 · NCT07855627Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
- MD Anderson Cancer Center, Houston
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06989099Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
- MD Anderson Cancer Center, Houston
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT06494111Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
- UTHealth Houston (The University of Texas Health Science Center at Houston), Houston
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT07613931Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
- MD Anderson Cancer Center, Houston
Renkami dalyviai2 fazė
Visi amžiai · Moterims · Atnaujinta 2026-07-24 · NCT06912763A Real-World Registry of Chronic Wounds and Ulcers
- US Wound Registry, The Woodlands
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-07-16 · NCT02280733LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
- MD Anderson, Houston
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-03-11 · NCT04606030Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.